Epithelioid angiomatosis. NLM AIDSLINE Important note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Epithelioid angiomatosis.

J Foot Ankle Surg. 1993 Jan-Feb;32(1):20-6. Unique Identifier : AIDSLINE MED/93306272
DeMarco MJ; Soroko TA; Kirsh S; Smith L; Department of Infectious Disease, Saint Michael's Medical Center,; Newark, New Jersey.

Abstract: Since the original description of Epithelioid Angiomatosis by Cockerell and Associates in 1987, literature has been published describing both the local and systemic manifestations of Cat-Scratch disease. Most typical cases of Cat-Scratch disease are self-limited with full recovery expected in 2 to 4 months. In patients infected with the acquired immunodeficiency virus, the prognosis is much less favorable. The authors present a case of a human immunodeficiency virus (HIV)-infected patient with biopsy proven Cat-Scratch disease, his clinical manifestations, and response to therapy.
Keywords: Acquired Immunodeficiency Syndrome/*COMPLICATIONS Adult Angiomatosis, Bacillary/COMPLICATIONS/*DIAGNOSIS/DRUG THERAPY Antibiotics, Combined/THERAPEUTIC USE AIDS-Related Opportunistic Infections/COMPLICATIONS/*DIAGNOSIS/ DRUG THERAPY Case Report Cat-Scratch Disease/COMPLICATIONS/*DIAGNOSIS/DRUG THERAPY Ciprofloxacin/THERAPEUTIC USE Erythromycin/THERAPEUTIC USE Human Male JOURNAL ARTICLE REVIEW REVIEW OF REPORTED CASESKWDacquiredimmunodeficiencysyndrome/KWDcomplicationsadultangiomatosis,bacillary/complications/KWDdiagnosis/drugtherapyantibiotics,combined/therapeuticuseaids-relatedopportunisticinfections/complications/KWDdiagnosis/drugtherapycasereportcat-scratchdisease/complications/KWDdiagnosis/drugtherapyciprofloxacin/therapeuticuseerythromycin/therapeuticusehumanmalejournalarticlereviewreviewofreportedcases
931030
M93A0716

Copyright © 1993 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .